ResearcherTianjin First Center HospitalActive in the last 2 years
Rende Guo
Matched on ORCID iD 0009-0005-8405-208X; OpenAlex author ID A5101824229.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 4 (first author 2, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell. Last author DOI 10.1007/s00210-024-03717-0↗
- MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39. First author DOI 10.1155/2017/2381482↗
- MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer. First author DOI 10.1002/iub.1342↗
- [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2]. Co-author DOI 10.3760/cma.j.issn.0253-3766.2013.01.004↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Guiming Wang · 1 shared paper, 2025
- Chuan Gu · 2 shared papers, 2015–2017
- Yuliang Wang · 1 shared paper, 2013
- Xu Han · 1 shared paper, 2013
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.